Mitral stenosis follow up

Jump to navigation Jump to search

Mitral Stenosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Mitral Stenosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Stages

History and Symptoms

Physical Examination

Electrocardiogram

Chest X Ray

Echocardiography

Cardiac MRI

Cardiac Catheterization

Treatment

Overview

Medical Therapy

Percutaneous Mitral Balloon Commissurotomy (PMBC)

Surgery

Follow Up

Prevention

Case Studies

Case #1

Mitral stenosis follow up On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mitral stenosis follow up

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA onMitral stenosis follow up

CDC on Mitral stenosis follow up

Mitral stenosis follow up in the news

Blogs on Mitral stenosis follow up

Directions to Hospitals Treating Mitral Stenosis

Risk calculators and risk factors for Mitral stenosis follow up

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Overview

Regular follow up is recommended among patients with asymptomatic mitral stenosis (MS) and preserved left ventricular ejection fraction.[1]

Follow Up

Echocardiography is performed for follow up among asymptomatic patients with MS to assess the left ventricular ejection fraction (LVEF) and end-systolic dimension. The frequency of follow up with an echocardiogram among asymptomatic patients with MS and normal LVEF is as follows:[1]

  • Progressive MS, stage B (mitral valve area >1.5 cm2): every 3-5 years
  • Severe MS, stage C (mitral valve area 1.0-1.5 cm2): every 1-2 years
  • Severe MS, stage C (mitral valve area <1.0 cm2): every year

References

  1. 1.0 1.1 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (23): 2440–92. doi:10.1161/CIR.0000000000000029. PMID 24589852.

Template:WikiDoc Sources